Alkem Laboratories Ltd Company History

Incorporation of the Company.

the Company established its first plant at Taloja, Maharashtra.

the Company became a deemed public limited company.

the Company established its manufacturing facility in Mandwa, Maharashtra. This facility was converted into an API facility in 2005.

the Company established its Kachigam manufacturing facility in Gujarat.

Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company.

the Company established its Amaliya manufacturing facility in Gujarat.

the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India’s Most Esteemed Pharmaceutical Company'

the Company set up its research and development facility at Taloja, Maharashtra.

the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004

the Company established its manufacturing facility in Baddi, Himachal Pradesh.

the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005

the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India (Source: IMS Research)

the Company established its manufacturing facility in Kumrek, Sikkim.

the Company filed its first ANDA in the United States for the drug, Amlodipine.

the Company shifted its Registered Office from Patna, Bihar to Mumbai, Maharashtra.

the Company acquired Pharmacor, a generic pharma company in Australia.

the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI

the Company received the certificate of appreciation in the category of ‘Formulation Experts’ by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI

the Company acquired The PharmaNetwork, LLC, the holding company of Ascend Laboratories LLC.

the Company acquired Enzene Bio sciences Limited.

the Company acquired an API manufacturing facility in the United States.

the Company was awarded the India’s most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013

the Company acquired the Clindac.

the Product ‘Clavam’ was awarded as the ‘ Brand of the Year’ at the AWACS Award, 2014

the Company acquired a formulation manufacturing facility in the United States.

Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA

Alkem receives EIR from the US FDA for its Daman formulation facility

Marketing alliance with Haw Par to excusively market, sell and distribute Tiger Balam range of Product in India.

Direct consumer marketing for pregakem and Livoerb

Alkem received the Best Stand-out IR award 2017 by IR Society India in association with KPMG and Bloomberg

Revenue from the US market Crossed USD 200 mn in annual sales

Brand 'Clavam' receiving Brand of the Year 2018 at AWACS AWARDS FOR Marketing Excellence

Crossed the reenue milestone of USD 1 billion

Express Pharma Excellence Award at Pharma CXO Sumit 2019

Alkem Laboratories takes over undertaking from Cachet Pharmaceuticals

Launch of Favipiravir in India under the brand name 'Alfluenza'

CIO Conclave and Awards 2020 'In the category Best IT team of the Year'

Launch of Ibuprofen and Famotidine Tablets in the United States

Launch of Perampanel Tablets in India unde the brand name 'Perampil'

Alkem Parners with Tata Memorial Hospital

Launch of Brivaracetam in India under the Brand name 'Brivasure'

India's Best Wrokplaces in Biotechnology & Pharmaceutical Industry for the second consecutive year

Alkem signs license agreement with Harvard University's Office of Technology Development.

The Company has informed that ,the Company and Biosergen AB have entered into a co-development and license agreement for development and commercialization of Biosergen''s novel polyene macrolide antifungal product BSG005 for the treatment of severe invasive fungal disease.

The NCLT has approved the Scheme of Amalgamation for merger of M/s. Pharmasofttech Awacs Pvt. Ltd. into M/s. Pharmarack Technologies Pvt. Ltd. Both these Companies are subsidiaries of M/s Aarogya Bharat Digital LLP (earlier known as M/s. DigiHealth Technologies LLP). which in turn is a wholly-owned subsidiary of our investee entity i.e. M/s. ABCD Technologies LLP.